Importantly, glucose transporter expression significantly changes in response to energy demands or under pathophysiological conditions; indeed, brain GLUT1 and GLUT3 protein levels are considerably lower in patients with AD and animal models of AD (20). This evidence concerns the gene SLC2A1 and Alzheimer disease.